Guarantee Agreements in the Biotechnology Industry
38 Contracts & Agreements
- AGENUS INC (1 contract)
- Amgen Inc. (2)
- AquaBounty Technologies, Inc. (1)
- ARCA biopharma, Inc. (1)
- AVEO PHARMACEUTICALS INC (1)
- Avita Therapeutics, Inc. (1)
- BeiGene, Ltd. (1)
- CONCERT PHARMACEUTICALS, INC. (1)
- CTI BIOPHARMA CORP (1)
- DYADIC INTERNATIONAL INC (1)
- Epizyme, Inc. (1)
- GeoVax Labs, Inc. (1)
- iBio, Inc. (1)
- Intellia Therapeutics, Inc. (1)
- INTREXON CORP (1)
- Karyopharm Therapeutics Inc. (1)
- Leisure Acquisition Corp. (3)
- Medovex Corp. (1)
- MEI Pharma, Inc. (1)
- OncBioMune Pharmaceuticals, Inc (2)
- OPGEN INC (2)
- Organicell Regenerative Medicine, Inc. (1)
- Ovid Therapeutics Inc. (1)
- PLURISTEM THERAPEUTICS INC (2)
- Retrophin, Inc. (1)
- SANGAMO THERAPEUTICS, INC (1)
- Sarepta Therapeutics, Inc. (1)
- SELLAS Life Sciences Group, Inc. (1)
- Tocagen Inc (1)
- VITAL THERAPIES INC (1)
- Xenetic Biosciences, Inc. (1)
- Zai Lab Ltd (1)
- Subsidiary Guarantee (DYADIC INTERNATIONAL INC, Filed With SEC on March 11, 2024)
- Supplement to Guarantee (Avita Therapeutics, Inc., Filed With SEC on February 22, 2024)
- Unofficial English Translation of Maximum-Amount Guarantee Contract, dated as of February (Zai Lab Ltd, Filed With SEC on February 8, 2024)
- Validity Guarantee, dated January 16, 2024 (iBio, Inc., Filed With SEC on January 19, 2024)
- Form of Subsidiary Guarantee to be entered into by and among the Company and the purchasers signatory thereto (Leisure Acquisition Corp., Filed With SEC on October 24, 2023)
- Subsidiary Guarantee, dated June 30, 2022, by and among the Company and the purchasers signatory thereto (Leisure Acquisition Corp., Filed With SEC on July 6, 2022)
- Guarantee by and among Precigen, Inc., Trans Ova Genetics, L.C., Spring Bidco LLC and Houdstermaatschappij Wilg B.V., dated as of July 1, 2022 (INTREXON CORP, Filed With SEC on July 5, 2022)
- Subsidiary Guarantee, dated September 24, 2021, by and among the Company and the purchasers signatory thereto (Leisure Acquisition Corp., Filed With SEC on September 27, 2021)
- Guarantee Agreement by and among the European Investment Bank, Pluristem Ltd. and Pluristem GmbH dated, September 30, 2020 (PLURISTEM THERAPEUTICS INC, Filed With SEC on November 5, 2020)
- Guarantee Agreement by and among the European Investment Bank, Pluristem Therapeutics, Inc. and Pluristem GmbH, dated September 30, 2020 (PLURISTEM THERAPEUTICS INC, Filed With SEC on November 5, 2020)
- Form of Guarantee Agreement between Immunic, Inc., Immunic AG and European Investment Bank (VITAL THERAPIES INC, Filed With SEC on October 20, 2020)
- Guarantee and Indemnity Agreement, dated as of July 9, 2020, by and between European Investment Bank and Ares Genetics (OPGEN INC, Filed With SEC on July 13, 2020)
- Guarantee and Indemnity Agreement, dated as of July 9, 2020, by and between European Investment Bank and the Company (OPGEN INC, Filed With SEC on July 13, 2020)
- Form of Subsidiary Guarantee dated June 26, 2020 (GeoVax Labs, Inc., Filed With SEC on June 26, 2020)
- Form of Subsidiary Guarantee dated April 17, 2020 (Medovex Corp., Filed With SEC on April 22, 2020)
- Guarantee, dated October 31, 2019, made by and between Amgen Inc. and the Registrant (BeiGene, Ltd., Filed With SEC on March 2, 2020)
- Guarantee, dated as of October 31, 2019, made by and among BeiGene, Ltd. and Amgen Inc (Amgen Inc., Filed With SEC on February 12, 2020)
- Irrevocable Guarantee, dated August 25, 2019, by and between Amgen Inc. and Bristol-Myers Squibb Company (Amgen Inc., Filed With SEC on August 26, 2019)
- Guarantee dated as of October 9, 2018, made by AquaBounty Technologies, Inc. in favor of Prince Edward Island Century 2000 Fund Inc (AquaBounty Technologies, Inc., Filed With SEC on November 2, 2018)
- Parent Company Guarantee, dated May 23, 2018, by Antengene Corporation Co. Ltd (Karyopharm Therapeutics Inc., Filed With SEC on August 7, 2018)
- Subsidiary Guarantee dated March 13, 2018 (OncBioMune Pharmaceuticals, Inc, Filed With SEC on May 31, 2018)
- Subsidiary Guarantee dated January 29, 2018 (OncBioMune Pharmaceuticals, Inc, Filed With SEC on May 31, 2018)
- Signature(s) Guaranteed: Medallion Guarantee Stamp (Ovid Therapeutics Inc., Filed With SEC on April 25, 2017)
- Signature(s) Guaranteed: Medallion Guarantee Stamp (Tocagen Inc, Filed With SEC on April 3, 2017)
- Form of the Subsidiary Guarantee, dated March 29, 2017, by and among Biotech Products Services and Research, Inc. and each of its Subsidiaries (Organicell Regenerative Medicine, Inc., Filed With SEC on April 3, 2017)
- Signature(s) Guaranteed:Medallion Guarantee Stamp (SANGAMO THERAPEUTICS, INC, Filed With SEC on January 6, 2017)
- Signature(s)Guaranteed: Medallion Guarantee Stamp (Intellia Therapeutics, Inc., Filed With SEC on May 17, 2016)
- SUBSIDIARY GUARANTEE (SELLAS Life Sciences Group, Inc., Filed With SEC on May 10, 2016)
- SUBSIDIARY GUARANTEE (Xenetic Biosciences, Inc., Filed With SEC on July 8, 2015)
- GUARANTEE AND COLLATERAL AGREEMENT dated as of June 30, 2014, among RETROPHIN, INC., as the Borrower THE GUARANTORS PARTY HERETO and U.S. BANK NATIONAL ASSOCIATION, as Collateral... (Retrophin, Inc., Filed With SEC on July 7, 2014)
- Signature(s)Guaranteed: Medallion Guarantee Stamp (CONCERT PHARMACEUTICALS, INC., Filed With SEC on February 3, 2014)
- Signature(s) Guaranteed: Medallion Guarantee Stamp (Sarepta Therapeutics, Inc., Filed With SEC on August 8, 2013)
- Signature(s) Guaranteed: Medallion Guarantee Stamp (Epizyme, Inc., Filed With SEC on April 26, 2013)
- Letter of Guarantee (CTI BIOPHARMA CORP, Filed With SEC on August 2, 2012)
- Signature(s) Guaranteed:Medallion Guarantee Stamp (AVEO PHARMACEUTICALS INC, Filed With SEC on March 9, 2010)
- Signature(s) Guaranteed: Medallion Guarantee Stamp (ARCA biopharma, Inc., Filed With SEC on January 28, 2009)
- ANTIGENICS INC. GUARANTEE Dated as of October 30, 2006 (AGENUS INC, Filed With SEC on October 31, 2006)
- GUARANTEE AND INDEMNITY (MEI Pharma, Inc., Filed With SEC on September 25, 2003)
